Online citations, reference lists, and bibliographies.
← Back to Search

Polymer‐based Delivery Systems For The Pulmonary Delivery Of Biopharmaceuticals

N. Kunda, Iman M. Alfagih, Iman M. Alfagih, I. Saleem, G. Hutcheon
Published 2015 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/J.BBRC.2004.04.067
Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases.
M. Brzoska (2004)
10.1080/02652040601162335
Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles
J. G. Eley (2007)
10.1016/S0168-3659(01)00373-X
POE-PEG-POE triblock copolymeric microspheres containing protein. I. Preparation and characterization.
Y. Yang (2001)
10.1186/rr58
The lung as a route for systemic delivery of therapeutic proteins and peptides
R. Uchenna Agu (2001)
10.1016/j.jconrel.2011.08.008
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
S. Al-Qadi (2012)
10.1517/17425247.3.1.87
Noninvasive delivery technologies: respiratory delivery of vaccines
V. Sullivan (2006)
10.1016/j.colsurfb.2012.10.063
Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.
L. Chronopoulou (2013)
10.1021/OP900013A
Particle Engineering Strategies via Crystallization for Pulmonary Drug Delivery
D. Ragab (2009)
10.1517/14712598.8.7.857
Spray drying TB vaccines for pulmonary administration
P. Fourie (2008)
10.1007/s11095-008-9800-3
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
10.1007/S00396-009-2131-Z
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
10.1039/c2cs35265f
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
Julien Nicolas (2013)
10.1016/J.VACCINE.2007.05.064
Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs.
M. Amidi (2007)
10.1016/S0140-6736(00)03638-2
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
J. Skyler (2001)
10.1517/17425247.2010.492212
Micro- and nanocarrier-mediated lung targeting
B. D. Kurmi (2010)
10.1016/j.jconrel.2010.02.018
Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
K. Mohri (2010)
10.1016/S0168-3659(03)00263-3
Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs.
K. Surendrakumar (2003)
10.1002/JBM.A.30421
Pulmonary inflammation caused by chitosan microparticles.
Y. Huang (2005)
10.1016/J.JCONREL.2003.09.019
Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase.
Y. Lo (2004)
10.1007/s11095-008-9559-6
Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
J-P. Amorij (2008)
10.1016/S0168-3659(97)00149-1
Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.
C. Évora (1998)
10.1021/mp900278x
Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications.
A. Beyerle (2010)
10.1055/S-0037-1615602
Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogs.
K. Russell (2001)
10.1007/978-1-59745-210-6_1
Drug delivery systems - an overview.
K. Jain (2008)
10.1016/j.jconrel.2011.08.011
Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
D. K. Jensen (2012)
10.1517/17425247.5.6.629
Biodegradable polymeric nanocarriers for pulmonary drug delivery
Erik Rytting (2008)
10.1248/BPB.24.385
Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane.
A. Yamamoto (2001)
10.1211/0022357001774444
Gelatin Microspheres as a Pulmonary Delivery System: Evaluation of Salmon Calcitonin Absorption
K. Morimoto (2000)
10.1002/(SICI)1099-1581(1998100)9:10/11<768::AID-PAT828>3.0.CO;2-O
Polymeric micelles as drug delivery systems: a reactive polymeric micelle carrying aldehyde groups
C. Scholz (1998)
10.1517/17425247.2.1.29
Commercial challenges of protein drug delivery
L. Brown (2005)
10.1517/17425240903307423
Recent advances in intravenous delivery of poorly water-soluble compounds
Y. Shi (2009)
10.1002/jps.22428
Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats.
Zhengqi Dong (2011)
10.1016/J.TIBTECH.2005.07.005
Biopharmaceuticals: recent approvals and likely directions.
G. Walsh (2005)
10.2174/138161209788923886
Nanocarriers in ocular drug delivery: an update review.
Sheetu Wadhwa (2009)
10.1208/s12249-009-9236-z
Effect of Sugars, Surfactant, and Tangential Flow Filtration on the Freeze-Drying of Poly(lactic acid) Nanoparticles
S. Hirsjärvi (2009)
10.1016/S0939-6411(02)00158-3
Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.
T. Nakate (2003)
10.1385/BTER:75:1-3:215
Lanthanides enhance pulmonary absorption of insulin
Zan-Cong Shen (2007)
10.1016/j.jconrel.2008.12.011
Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
F. Ungaro (2009)
10.2147/IJN.S4937
Nanomedicine in pulmonary delivery
H. M. Mansour (2009)
10.1016/S0264-410X(98)00438-1
Dry powder inhalation as a potential delivery method for vaccines.
C. Licalsi (1999)
10.1023/A:1016029317299
Effects of Phospholipid Chain Length, Concentration, Charge, and Vesicle Size on Pulmonary Insulin Absorption
Y. Li (2004)
10.1016/j.addr.2007.09.001
Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications.
K. Byrappa (2008)
10.1517/17425247.4.6.607
The nanoscale in pulmonary delivery. Part 2: formulation platforms
P. Rogueda (2007)
10.1023/A:1026118813943
Pulmonary Absorption of Insulin Mediated by Tetradecyl-β-Maltoside and Dimethyl-β-Cyclodextrin
Alamdar Hussain (2004)
10.1016/S0378-5173(01)00945-0
The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation.
K. Ståhl (2002)
10.1016/j.nano.2010.10.007
Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro.
M. Beck-Broichsitter (2011)
10.1289/EHP.01109S4547
Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats.
S. Takenaka (2001)
10.1016/S0041-008X(02)00024-8
Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis.
A. Nemmar (2003)
10.1007/s11095-012-0891-5
Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery
N. Kunda (2012)
10.1016/J.ADDR.2006.09.017
Freeze-drying of nanoparticles: formulation, process and storage considerations.
W. Abdelwahed (2006)
10.1016/J.JCONREL.2003.11.005
Ultrasonic atomisation into reduced pressure atmosphere--envisaging aseptic spray-drying for microencapsulation.
S. Freitas (2004)
10.1002/bdd.702
Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats
H. Hamishehkar (2010)
10.1016/j.ejps.2009.02.008
ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells.
Chuda Chittasupho (2009)
10.1517/13543776.18.4.429
Dry powder inhalation systems for pulmonary delivery of therapeutic peptides and proteins
S. Onoue (2008)
10.1016/J.TAAP.2006.01.016
Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung.
L. A. Dailey (2006)
10.1016/J.TIBTECH.2007.09.005
Nanoparticles for drug delivery to the lungs.
Jean Sung (2007)
10.1016/S0168-3659(99)00048-6
Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.
Y. Kawashima (1999)
10.1016/S0168-3659(00)00362-X
Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.
C. Bosquillon (2001)
10.1016/J.JCONREL.2004.10.010
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.
H. Yamamoto (2005)
10.1016/0169-409X(95)00113-L
Mechanisms of macromolecule absorption by the lungs
John S. Patton (1996)
10.1023/A:1018950429341
Improvement of the Pulmonary Absorption of (Asu1,7)-Eel Calcitonin by Various Protease Inhibitors in Rats
T. Morita (2004)
10.1080/02652040500435287
Encapsulation of BSA using a modified W/O/O emulsion solvent removal method
D. Ciombor (2006)
10.1016/J.JCONREL.2006.08.013
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1016/J.EJPB.2007.05.007
Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery.
M. Amidi (2008)
10.1016/J.EJPS.2005.04.009
Microencapsulated chitosan nanoparticles for lung protein delivery.
A. Grenha (2005)
10.3109/01902149209031697
Passage of aerosolized BSA and the nona-peptide dDAVP via the respiratory tract in young and adult rats.
H. Folkesson (1992)
10.1016/j.ijpharm.2012.10.036
Dry powder inhalation of macromolecules using novel PEG-co-polyester microparticle carriers.
Hesham M Tawfeek (2013)
10.1073/PNAS.71.5.1743
Replication and transcription of eukaryotic DNA in Escherichia coli.
J. F. Morrow (1974)
10.1016/J.ADDR.2006.07.009
Clinical perspectives on pulmonary systemic and macromolecular delivery.
G. Scheuch (2006)
10.1208/s12248-010-9192-2
Immunization of Guinea Pigs with Novel Hepatitis B Antigen as Nanoparticle Aggregate Powders Administered by the Pulmonary Route
Pavan Muttil (2010)
10.1615/CRITREVTHERDRUGCARRIERSYST.V12.I2-3.20
Delivery of biotherapeutics by inhalation aerosol.
R. Niven (1995)
10.1016/J.ADDR.2007.02.002
Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation.
H. Okamoto (2008)
10.1007/s11095-006-9563-7
Gene Expression Profiles in Mouse Lung Tissue after Administration of Two Cationic Polymers Used for Nonviral Gene Delivery
K. Regnström (2006)
10.1111/j.2042-7158.2012.01486.x
Engineered PLGA nano‐ and micro‐carriers for pulmonary delivery: challenges and promises
F. Ungaro (2012)
10.1016/S0928-0987(02)00133-1
Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate.
F. Johansson (2002)
10.1016/j.ejpb.2011.01.007
State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.
R. Mueller (2011)
10.1016/j.ijpharm.2010.03.017
Formulation strategy and use of excipients in pulmonary drug delivery.
G. Pilcer (2010)
10.2147/IJN.S1045
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases
Malgorzata Smola (2008)
10.1016/J.PROGPOLYMSCI.2013.07.005
Dendrimer as nanocarrier for drug delivery
P. Kesharwani (2014)
10.1186/1479-0556-1-3
Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma
M. Kumar (2003)
10.1007/s11095-007-9475-1
Pharmaceutical Particle Engineering via Spray Drying
R. Vehring (2007)
10.1513/PATS.200409-049TA
The lungs as a portal of entry for systemic drug delivery.
John S. Patton (2004)
10.1016/J.JCONREL.2003.10.001
Absorption enhancers in pulmonary protein delivery.
Alamdar Hussain (2004)
10.1023/A:1018926007902
Study on Pulmonary Delivery of Salmon Calcitonin in Rats: Effects of Protease Inhibitors and Absorption Enhancers
Shinzo Kobayashi (2004)
10.1016/j.ijpharm.2008.07.004
Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
M. Anhorn (2008)
10.1155/2013/340315
Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
W. Xu (2013)
10.1016/j.peptides.2010.10.003
Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation
S. C. Yadav (2011)
10.1016/j.ijpharm.2013.02.031
Inhaled proteins: challenges and perspectives.
F. Depreter (2013)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
10.1208/ps050209
Evaluation of novel particles as pulmonary delivery systems for insulin in rats
L. García-Contreras (2008)
10.1016/j.addr.2010.11.002
Formation, characterization, and fate of inhaled drug nanoparticles.
J. Zhang (2011)
10.1016/J.IJPHARM.2003.09.041
Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
Jeffrey O-H Sham (2004)
10.1007/s11095-011-0433-6
Poly(Glycerol Adipate-co-ω-Pentadecalactone) Spray-Dried Microparticles as Sustained Release Carriers for Pulmonary Delivery
Hesham M Tawfeek (2011)
10.1016/j.biochi.2010.05.010
Lung protease/anti-protease network and modulation of mucus production and surfactant activity.
I. Garcia-Verdugo (2010)
10.1016/j.jconrel.2009.10.016
Nanotechnology and the transdermal route: A state of the art review and critical appraisal.
G. Cevc (2010)
10.1016/J.ADDR.2006.07.010
Particle engineering techniques for inhaled biopharmaceuticals.
S. Shoyele (2006)
10.1007/s10439-009-9734-x
Disulfide-Crosslinked Polyion Micelles for Delivery of Protein Therapeutics
M. J. Heffernan (2009)
10.1039/B309043B
Dendrimers in drug research.
U. Boas (2004)
10.1016/j.ejps.2009.07.008
Dendrimers: emerging polymers for drug-delivery systems.
B. Nanjwade (2009)
10.1016/S0378-5173(01)00614-7
Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.
Q. Zhang (2001)
10.2337/DIACARE.25.12.2276
Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes.
A. D. Perera (2002)
10.1016/0013-9351(76)90107-9
Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation.
J. Brain (1976)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar